TY - JOUR T1 - Spironolactone of no benefit in people with AF and HFpEF JF - Drug and Therapeutics Bulletin JO - Drug Ther Bull SP - 181 LP - 181 DO - 10.1136/dtb.2021.000058 VL - 59 IS - 12 A2 - , Y1 - 2021/12/01 UR - http://dtb.bmj.com/content/59/12/181.abstract N2 - Overview of: Shantsila E, Shahid F, Sun Y, et al. Spironolactone to improve exercise tolerance in people with permanent atrial fibrillation and preserved ejection fraction: the IMPRESS-AF RCT. Efficacy Mech Eval 2020; 7(4). ER -